Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

11.35
Delayed Data
As of Jul 21
 -0.12 / -1.05%
Today’s Change
4.88
Today|||52-Week Range
12.04
+63.54%
Year-to-Date
Ironwood (IRWD) Reports Positive Data on Reflux Candidate
Jul 21 / Zacks.com - Paid Partner Content
BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug
Jul 13 / Zacks.com - Paid Partner Content
Galapagos (GLPG) Looks Good: Stock Adds 6.2% in Session
Jul 21 / Zacks.com - Paid Partner Content
Mallinckrodt's MNK-1411 Gets Orphan Drug Status for DMD
Jul 13 / Zacks.com - Paid Partner Content
Emergent Inks Agreement to Acquire Anthrax Drug Raxibacumab
Jul 20 / Zacks.com - Paid Partner Content
Corcept Therapeutics Focuses on Korlym's Label Expansion
Jul 13 / Zacks.com - Paid Partner Content
Sarepta & BioMarin Settle Patent Litigation on Exon Skipping
Jul 19 / Zacks.com - Paid Partner Content
5 Stocks with Recent Price Strength to Enhance Your Returns
Jul 13 / Zacks.com - Paid Partner Content
Vertex (VRTX) Triple Combination CF Studies Data Positive
Jul 19 / Zacks.com - Paid Partner Content
Endocyte (ECYT) to Focus on Promising CAR-T Cell Platform
Jul 13 / Zacks.com - Paid Partner Content
Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt
Jul 19 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Bio...
Jul 12 / Zacks.com - Paid Partner Content
Repros' Proellex Stays on Partial Clinical Hold, Shares Fall
Jul 18 / Zacks.com - Paid Partner Content
Arena Announces Secondary Stock Offering of 150M Shares
Jul 12 / Zacks.com - Paid Partner Content
Perrigo Company Gets FDA Approval for Generic Topical Gel
Jul 18 / Zacks.com - Paid Partner Content
Mallinckrodt to Pay $35M for Controlled Substances Probe
Jul 12 / Zacks.com - Paid Partner Content
Arena Announces Secondary Stock Worth $150M (revised)
Jul 17 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Positive Data on Hemophilia A Drug
Jul 11 / Zacks.com - Paid Partner Content
Emergent BioSolutions to Buy Sanofi's Smallpox Vaccine Unit
Jul 17 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Stock Down Despite Positive Hemophilia Data
Jul 11 / Zacks.com - Paid Partner Content
Gilead (GILD) Application for HIV Drug Validated in EU
Jul 15 / Zacks.com - Paid Partner Content
5 Top Multibagger Biotech Stocks to Buy in the 2nd Half
Jul 11 / Zacks.com - Paid Partner Content
Gilead (GILD) Application for HIV Drug Validated in EU
Jul 14 / Zacks.com - Paid Partner Content
Alnylam Commences Phase III Study for Hemophilia Candidate
Jul 10 / Zacks.com - Paid Partner Content
Can Enzo Biochem (ENZ) Run Higher on Strong Earnings Estimate Revisions?
Jul 14 / Zacks.com - Paid Partner Content
Prima Biomed's Intra-Tumor Study on Lead Candidate Approved
Jul 10 / Zacks.com - Paid Partner Content
Gemphire Therapeutics (GEMP) Catches Eye: Stock Gains 9.7%
Jul 14 / Zacks.com - Paid Partner Content
DBV Technologies (DBVT) Worth a Look: Stock Up 5.7%
Jul 10 / Zacks.com - Paid Partner Content